The cost-effectiveness of group cognitive behavioral therapy compared with routine primary care for women with postnatal depression in the UK.
OBJECTIVE
To assess the cost-effectiveness of group cognitive behavior therapy (gCBT) in comparison with routine primary care for women with postnatal depression in the UK.


METHODS
Our analysis was based on a systematic literature review of the relative clinical effectiveness of gCBT compared with routine primary care and further reviews, supplemented with expert opinion of the likely cost of providing gCBT and the duration of comparative advantage for gCBT. Raw data were used to estimate a statistical relationship between changes in the Edinburgh Postnatal Depression Score (EPDS) values and changes in short-form six dimensions' (SF-6D) values. A mathematical model was constructed, and probabilistic sensitivity analyses were undertaken to estimate the mean cost per quality-adjusted life-year (QALY) and to evaluate the expected value of perfect information (EVPI).


RESULTS
The mean cost per QALY from the stochastic analysis was estimated to be pound36,062; however, there was considerable uncertainty around this value. The EVPI was estimated to be greater than pound64 million; the key uncertainties were in the cost per woman of providing treatment and in the statistical relationship between changes in EPDS values and changes in SF-6D values. The expected value of perfect partial information for both of these parameters was in excess of pound25 million.


CONCLUSIONS
Given the current information, the use of gCBT does not appear to be cost-effective; however, this decision is uncertain. The value of information analyses conducted indicates that further research to provide robust information on key parameters is needed and appears justified in cost-effective terms.
Stevenson
Matt D
MD
School of Health and Related Research, University of Sheffield, Sheffield, UK. m.d.stevenson@shef.ac.uk
Scope
Alison
A
Sutcliffe
Paul A
PA
D015928:Cognitive Behavioral Therapy / Q000191:economics*; D016001:Confidence Intervals; D003362:Cost-Benefit Analysis; D019052:Depression, Postpartum / Q000191:economics* / Q000628:therapy*; D005260:Female; D006305:Health Status Indicators; D006801:Humans; D008962:Models, Theoretical; D011247:Pregnancy; D011320:Primary Health Care / Q000191:economics*; D011336:Probability; D011594:Psychometrics; D011615:Psychotherapy, Group / Q000191:economics*; D019057:Quality-Adjusted Life Years; D006113:United Kingdom